申请人:Micro Labs Ltd.
公开号:US11345664B2
公开(公告)日:2022-05-31
The present invention relates to a process for the preparation of (S)-Netarsudil or its pharmaceutically acceptable salts using novel intermediates. The present invention further provides novel salts, novel intermediates and novel polymorphic forms of the (S)-Netarsudil salts and process for the preparation of the same.
本发明涉及一种使用新型中间体制备 (S)-Netarsudil 或其药学上可接受的盐的工艺。本发明进一步提供了(S)-Netarsudil 盐的新型盐、新型中间体和新型多晶型,以及制备这些盐的工艺。